Search for a Writer:
Calculated Writer Scores
- Frequency of opinion markers: Low
- Sentiment markers: Mostly Neutral
- What is this?
Community Writer Scores
Coverage
- World: 0%
- National: 40%
- Science and Technology: 10%
- Business: 50%
- Entertainment: 0%
Words Associated with BERNADETTE TANSEY
Most Frequently Mentioned Topics
Sources They're Writing For (last 60 days)
Writer Feed Widget
Grab this free widget and get the latest news for this writer. You can post it on your web page or blog, or add it to your desktop. Click on the "get & share" button at the bottom.
Articles Written by: BERNADETTE TANSEY
If you live in the Bay Area, chances are good that you're close to a company with biotechnology ties.
The Bay Area, where the biotech industry was born in the 1970s, remains the world's largest cluster of biotech enterprise.
Alongside the well-known ...
Quick links to the best of SFGate | Still can't find it? see Site Index
In the late 1800s, Karl Marx in his magnum opus "Das Kapital" predicted that "as the boom and bust cycles of capitalism became progressively worse, it would eventually destroy ...
(03-26) 13:50 PDT SOUTH SAN FRANCISCO --
Swiss drugmaker Roche said Thursday it completed its acquisition of biotechnology pioneer Genentech Inc. by sweeping up enough shares through a tender offer to gain ownership of more than 93 percent of Genentech' ...
The automated test for active TB illness, which gives results in two hours or less, also alerts doctors if a patient is infected with a drug-resistant strain of the bacterium that would not respond to standard treatment, Cepheid's chief medical officer ...
Quick links to the best of SFGate | Still can't find it? see Site Index
Infosys co-founder Nandan Nilekani calls himself a member of India's "bridge generation." When he was 5 years old, his father reverently took the whole family to hear Prime ...
Roche, which is in the process of acquiring Genentech of South San Francisco, did not say how much longer clinical trial subjects lived when they were treated with Herceptin and chemotherapy compared with the survival times of trial participants ...
The Oakland health maintenance organization, which has spent as much as $5 billion over the past five years building up its electronic records system, said Monday it has inked a seven-year deal with IBM to maximize the performance of its data ...
Related Topics:
IBM
The deal, at $95 per share, ends eight months of passionate haggling between the two companies over the surrender of the 44 percent of Genentech shares Roche didn't already own. But it still leaves Roche with the task of retaining top talent when it ...
The two companies said Thursday they had reached agreement in private negotiations to allow Roche to purchase the 44 percent of shares it doesn't already own in the South San Francisco biotechnology pioneer for $46.8 billion in cash.
The deal ends ...
Neither company would confirm a report in the Wall Street Journal on Monday that the pioneering South San Francisco biotechnology company had agreed to an acquisition at $95 a share, or $46.7 billion, for the stake in the company Roche doesn't already ...
